Vaccination Recommendations for Patients with Nephrotic Syndrome
Core Inactivated Vaccine Recommendations
- All individuals with nephrotic syndrome should receive influenza, pneumococcal, and varicella vaccines, and COVID‑19 vaccination is strongly recommended. [1][2]
- Adults aged 19–64 years with nephrotic syndrome should be immunized with either a single dose of PCV20 or PCV15 followed by PPSV23 after a minimum interval of 8 weeks. 3
- Adults aged ≥ 65 years with nephrotic syndrome should receive the same PCV20 or PCV15 → PPSV23 schedule. 3
- Patients with nephrotic syndrome secondary to chronic renal failure should receive a repeat dose of PPSV23 five years after the initial PPSV23 dose. [4][5]6
- Children with nephrotic syndrome should follow the age‑appropriate pneumococcal conjugate vaccine series. [7][8]
- Annual influenza vaccination is recommended for every patient with nephrotic syndrome. [1][2]7
- Household contacts of patients with nephrotic syndrome should also receive annual influenza vaccination to reduce transmission risk. [7][8]
- Hepatitis B vaccination is indicated for patients with chronic renal failure or those receiving hemodialysis. The standard three‑dose schedule (0, 1, 6 months) should be completed. [4][5]6
- All eligible and willing patients with nephrotic syndrome should be immunized against SARS‑CoV‑2 (COVID‑19). [1][2]
Live Vaccine Timing and Contraindications
- Live vaccines (MMR, varicella, zoster) should be deferred until the prednisone dose is ≤ 1 mg/kg daily (or ≤ 2 mg/kg on alternate days). [7][8]9
- Live vaccines are absolutely contraindicated in children receiving corticosteroid‑sparing immunosuppressants such as cyclophosphamide, rituximab, calcineurin inhibitors, or mycophenolate. [7][8]9
- The varicella vaccine may be administered once the above immunosuppression criteria are met. [1][2]7
- For non‑immune children on immunosuppressive therapy who have close varicella exposure, varicella‑zoster immune globulin should be given if available. [7][8]
Household‑Contact Vaccination Strategy
- Healthy household members should receive live vaccines to create a protective barrier, but direct exposure of the immunosuppressed patient to the vaccinated person’s gastrointestinal, urinary, or respiratory secretions should be avoided for 3–6 weeks after vaccination. [7][8]
- This precaution is especially relevant for rotavirus vaccination in infant siblings. 9
Special Considerations for Complement‑Inhibitor Therapy
- Patients receiving complement inhibitors (e.g., eculizumab, ravulizumab) must be vaccinated against meningococcal disease (both quadrivalent and serogroup B formulations). [1][2]
- Pneumococcal vaccination should be up to date before initiating complement‑inhibitor therapy. [1][2]
Infection Prophylaxis Beyond Vaccination
- Trimethoprim‑sulfamethoxazole (or an equivalent agent) should be used for Pneumocystis jirovecii prophylaxis when the daily prednisone dose is ≥ 20 mg. [1][2]
- PJP prophylaxis is also indicated for patients receiving cyclophosphamide or rituximab, irrespective of steroid dose. [1][2]
Common Pitfalls to Avoid
- Do not delay pneumococcal vaccination; the risk of infection is highest within the first six months after nephrotic‑syndrome diagnosis, particularly when serum albumin is low. [1][2]
- Do not administer live vaccines to patients on any immunosuppressive agent beyond low‑dose corticosteroids, including calcineurin inhibitors, rituximab, cyclophosphamide, and mycophenolate. [7][8]9
- Prior to initiating immunosuppression, screen patients for latent infections such as tuberculosis, hepatitis B/C, HIV, syphilis, and Strongyloides (in at‑risk individuals with eosinophilia). [1][2]
Vaccination Recommendations for Patients with Nephrotic Syndrome
Pneumococcal Revaccination
- Patients whose nephrotic syndrome is secondary to chronic renal failure should receive a repeat dose of the 23‑valent pneumococcal polysaccharide vaccine (PPSV23) five years after the initial PPSV23 dose. 10, 11
Influenza Vaccination
- An annual inactivated influenza vaccine is required for every patient with nephrotic syndrome, irrespective of whether they are receiving immunosuppressive therapy. 10, 11
Hepatitis B Vaccination and Serologic Monitoring
- Hepatitis B vaccination is indicated for patients with chronic renal failure and for those undergoing hemodialysis. 10, 11
- The vaccination schedule consists of three doses administered at 0, 1, and 6 months. 10, 11
- After completing the series, anti‑HBs antibody titers should be measured 6–12 weeks later; titers are then checked annually, and a repeat vaccine series is recommended if the titer falls below 10 mIU/mL. 12, 13, 14
Vaccination Strategy for Kidney Transplant Recipients with Prior Nephrotic Syndrome
- All inactivated vaccines (except influenza) should be withheld during the first six months after transplantation. 12, 13, 14
- Immunizations may be resumed once the patient is on minimal maintenance immunosuppression. 12, 13, 14
- The influenza vaccine should be administered at least one month after transplantation, regardless of the current level of immunosuppression. 12, 13, 14
- Live vaccines are contraindicated in kidney transplant recipients at any time post‑transplant. 12, 13, 14